Central motor conduction time in children and adolescents with insulin-dependent diabetes mellitus (IDDM)

Giuseppe d'Annunzio, Arrigo Moglia, Cinzia Zandrini, Elisabetta Bollani, Letizia Vitali, Paola Pessino, Andrea Scaramuzza, Giovanni Lanzi, Renata Lorini

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Measurement of central motor conduction time (CMCT) after percutaneous magnetic stimulation of the brain is an electrophysiological method that may discover subclinical impairment of central nervous system (CNS). In order to detect an impairment of CNS, we measured CMCT right (R) and left (L) after percutaneous stimulation of the brain in 34 patients affected by insulin-dependent diabetes mellitus (IDDM) (16 males and 18 females), aged 16.4 ± 4.1 years (7.3-23.2 years), with duration of disease 7.6 ± 4.9 years ( 7 12-16 years), and HbA1c annual mean 7.41 ± 1.1% (n.v. 5.14 ± 0.84%). Twenty-three sex- and age-matched healthy subjects served as controls. In our IDDM patients we observed a delay of CMCT R (P <0.0005) and L (P <0.0005) as compared to controls. No correlation was found between CMCT (R and L) and chronologic age, duration of disease, peroneal motor nerve conduction velocity. No association was observed between CMCT (R and L) and HLA antigens. On the basis of IDDM duration, patients were divided into 2 groups (G): G I (9 pts) with IDDM <2 years and G II (25 pts) with IDDM > 5 years, 12 of them with precocious signs of one or more microangiopathic complications. No difference in CMCT (R and L) was observed between the 2 groups and between G I and controls; G II patients had a longer delay of CMCT R (P <0.0001) and L (P <0.0001) than controls. In G II patients, a positive correlation between CMCT R and HbA1c of the 5 years before the test (P <0.025) was also observed. In the 12 of G II patients with precocious retinopathy and/or nephropathy, a positive correlation was found between CMCT R and HbA1c levels over the 5 years (P = 0.005) before the test. Our results show a delay in CMCT, related with the degree of metabolic control in patients with longstanding IDDM and/or microangiopathic complications.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalDiabetes Research and Clinical Practice
Volume28
Issue number1
DOIs
Publication statusPublished - 1995

Fingerprint

Type 1 Diabetes Mellitus
Central Nervous System
Brain
Healthy Volunteers

Keywords

  • Central nervous system
  • Diabetic neuropathy
  • Insulin-dependent diabetes mellitus
  • Neurophysiological tests

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Central motor conduction time in children and adolescents with insulin-dependent diabetes mellitus (IDDM). / d'Annunzio, Giuseppe; Moglia, Arrigo; Zandrini, Cinzia; Bollani, Elisabetta; Vitali, Letizia; Pessino, Paola; Scaramuzza, Andrea; Lanzi, Giovanni; Lorini, Renata.

In: Diabetes Research and Clinical Practice, Vol. 28, No. 1, 1995, p. 57-62.

Research output: Contribution to journalArticle

d'Annunzio, G, Moglia, A, Zandrini, C, Bollani, E, Vitali, L, Pessino, P, Scaramuzza, A, Lanzi, G & Lorini, R 1995, 'Central motor conduction time in children and adolescents with insulin-dependent diabetes mellitus (IDDM)', Diabetes Research and Clinical Practice, vol. 28, no. 1, pp. 57-62. https://doi.org/10.1016/0168-8227(95)01062-I
d'Annunzio, Giuseppe ; Moglia, Arrigo ; Zandrini, Cinzia ; Bollani, Elisabetta ; Vitali, Letizia ; Pessino, Paola ; Scaramuzza, Andrea ; Lanzi, Giovanni ; Lorini, Renata. / Central motor conduction time in children and adolescents with insulin-dependent diabetes mellitus (IDDM). In: Diabetes Research and Clinical Practice. 1995 ; Vol. 28, No. 1. pp. 57-62.
@article{dadd037d27bb4d7e8d981b8e7c530ce8,
title = "Central motor conduction time in children and adolescents with insulin-dependent diabetes mellitus (IDDM)",
abstract = "Measurement of central motor conduction time (CMCT) after percutaneous magnetic stimulation of the brain is an electrophysiological method that may discover subclinical impairment of central nervous system (CNS). In order to detect an impairment of CNS, we measured CMCT right (R) and left (L) after percutaneous stimulation of the brain in 34 patients affected by insulin-dependent diabetes mellitus (IDDM) (16 males and 18 females), aged 16.4 ± 4.1 years (7.3-23.2 years), with duration of disease 7.6 ± 4.9 years ( 7 12-16 years), and HbA1c annual mean 7.41 ± 1.1{\%} (n.v. 5.14 ± 0.84{\%}). Twenty-three sex- and age-matched healthy subjects served as controls. In our IDDM patients we observed a delay of CMCT R (P <0.0005) and L (P <0.0005) as compared to controls. No correlation was found between CMCT (R and L) and chronologic age, duration of disease, peroneal motor nerve conduction velocity. No association was observed between CMCT (R and L) and HLA antigens. On the basis of IDDM duration, patients were divided into 2 groups (G): G I (9 pts) with IDDM <2 years and G II (25 pts) with IDDM > 5 years, 12 of them with precocious signs of one or more microangiopathic complications. No difference in CMCT (R and L) was observed between the 2 groups and between G I and controls; G II patients had a longer delay of CMCT R (P <0.0001) and L (P <0.0001) than controls. In G II patients, a positive correlation between CMCT R and HbA1c of the 5 years before the test (P <0.025) was also observed. In the 12 of G II patients with precocious retinopathy and/or nephropathy, a positive correlation was found between CMCT R and HbA1c levels over the 5 years (P = 0.005) before the test. Our results show a delay in CMCT, related with the degree of metabolic control in patients with longstanding IDDM and/or microangiopathic complications.",
keywords = "Central nervous system, Diabetic neuropathy, Insulin-dependent diabetes mellitus, Neurophysiological tests",
author = "Giuseppe d'Annunzio and Arrigo Moglia and Cinzia Zandrini and Elisabetta Bollani and Letizia Vitali and Paola Pessino and Andrea Scaramuzza and Giovanni Lanzi and Renata Lorini",
year = "1995",
doi = "10.1016/0168-8227(95)01062-I",
language = "English",
volume = "28",
pages = "57--62",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Central motor conduction time in children and adolescents with insulin-dependent diabetes mellitus (IDDM)

AU - d'Annunzio, Giuseppe

AU - Moglia, Arrigo

AU - Zandrini, Cinzia

AU - Bollani, Elisabetta

AU - Vitali, Letizia

AU - Pessino, Paola

AU - Scaramuzza, Andrea

AU - Lanzi, Giovanni

AU - Lorini, Renata

PY - 1995

Y1 - 1995

N2 - Measurement of central motor conduction time (CMCT) after percutaneous magnetic stimulation of the brain is an electrophysiological method that may discover subclinical impairment of central nervous system (CNS). In order to detect an impairment of CNS, we measured CMCT right (R) and left (L) after percutaneous stimulation of the brain in 34 patients affected by insulin-dependent diabetes mellitus (IDDM) (16 males and 18 females), aged 16.4 ± 4.1 years (7.3-23.2 years), with duration of disease 7.6 ± 4.9 years ( 7 12-16 years), and HbA1c annual mean 7.41 ± 1.1% (n.v. 5.14 ± 0.84%). Twenty-three sex- and age-matched healthy subjects served as controls. In our IDDM patients we observed a delay of CMCT R (P <0.0005) and L (P <0.0005) as compared to controls. No correlation was found between CMCT (R and L) and chronologic age, duration of disease, peroneal motor nerve conduction velocity. No association was observed between CMCT (R and L) and HLA antigens. On the basis of IDDM duration, patients were divided into 2 groups (G): G I (9 pts) with IDDM <2 years and G II (25 pts) with IDDM > 5 years, 12 of them with precocious signs of one or more microangiopathic complications. No difference in CMCT (R and L) was observed between the 2 groups and between G I and controls; G II patients had a longer delay of CMCT R (P <0.0001) and L (P <0.0001) than controls. In G II patients, a positive correlation between CMCT R and HbA1c of the 5 years before the test (P <0.025) was also observed. In the 12 of G II patients with precocious retinopathy and/or nephropathy, a positive correlation was found between CMCT R and HbA1c levels over the 5 years (P = 0.005) before the test. Our results show a delay in CMCT, related with the degree of metabolic control in patients with longstanding IDDM and/or microangiopathic complications.

AB - Measurement of central motor conduction time (CMCT) after percutaneous magnetic stimulation of the brain is an electrophysiological method that may discover subclinical impairment of central nervous system (CNS). In order to detect an impairment of CNS, we measured CMCT right (R) and left (L) after percutaneous stimulation of the brain in 34 patients affected by insulin-dependent diabetes mellitus (IDDM) (16 males and 18 females), aged 16.4 ± 4.1 years (7.3-23.2 years), with duration of disease 7.6 ± 4.9 years ( 7 12-16 years), and HbA1c annual mean 7.41 ± 1.1% (n.v. 5.14 ± 0.84%). Twenty-three sex- and age-matched healthy subjects served as controls. In our IDDM patients we observed a delay of CMCT R (P <0.0005) and L (P <0.0005) as compared to controls. No correlation was found between CMCT (R and L) and chronologic age, duration of disease, peroneal motor nerve conduction velocity. No association was observed between CMCT (R and L) and HLA antigens. On the basis of IDDM duration, patients were divided into 2 groups (G): G I (9 pts) with IDDM <2 years and G II (25 pts) with IDDM > 5 years, 12 of them with precocious signs of one or more microangiopathic complications. No difference in CMCT (R and L) was observed between the 2 groups and between G I and controls; G II patients had a longer delay of CMCT R (P <0.0001) and L (P <0.0001) than controls. In G II patients, a positive correlation between CMCT R and HbA1c of the 5 years before the test (P <0.025) was also observed. In the 12 of G II patients with precocious retinopathy and/or nephropathy, a positive correlation was found between CMCT R and HbA1c levels over the 5 years (P = 0.005) before the test. Our results show a delay in CMCT, related with the degree of metabolic control in patients with longstanding IDDM and/or microangiopathic complications.

KW - Central nervous system

KW - Diabetic neuropathy

KW - Insulin-dependent diabetes mellitus

KW - Neurophysiological tests

UR - http://www.scopus.com/inward/record.url?scp=0029121604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029121604&partnerID=8YFLogxK

U2 - 10.1016/0168-8227(95)01062-I

DO - 10.1016/0168-8227(95)01062-I

M3 - Article

C2 - 7587914

AN - SCOPUS:0029121604

VL - 28

SP - 57

EP - 62

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 1

ER -